연구
연구업적
최근 5년 연구업적 현황
| 연도 | 2025년 | 2024년 | 2023년 | 2022년 | 2021년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 196편 | 179편 | 173편 | 163편 | 184편 |
| 공동 | 132편 | 147편 | 120편 | 115편 | 136편 | |
| 합계 | 328편 | 326편 | 293편 | 278편 | 320편 | |
1705. Optimal Patient Selection for Trastuzumab Treatment
in HER2-Positive Advanced Gastric Cancer.
Ock CY, Lee KW, Kim JW, Kim JS, Kim TY, Lee KH,
Han SW, Im SA, Kim TY, Kim WH, Bang YJ, Oh DY.
Clin Cancer Res.
2015 Jun 1;21(11):2520-9.
Link
1704. Phase I Study of CKD-516, a Novel Vascular Disrupting Agent, in Patients with Advanced Solid Tumors.
Oh DY, Kim TM, Han SW, Shin DY, Lee YG, Lee KW, Kim JH, Kim TY, Jang IJ, Lee JS, Bang YJ.
Cancer Res Treat. 2015 Feb 23.
[Epub ahead of print]
Link
1703. The Impact of Diabetes Mellitus and Metformin Treatment on
Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy.
Choi Y, Kim TY, Oh DY, Lee KH,
Han SW, Im SA, Kim TY, Bang YJ.
Cancer Res Treat.
2016 Jan;48(1):171-9.
Link
1702. Weight loss at the first month of palliative chemotherapy
predicts survival outcomes in patients with advanced gastric cancer.
Ock CY, Oh DY, Lee J, Kim TY, Lee KH,
Han SW, Im SA, Kim TY, Bang YJ.
Gastric Cancer. 2015 Mar 8.
[Epub ahead of print]
Link
1701. A randomized, multicenter, phase II/III study to determine the optimal dose
and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09.
Lee KH, Kim JY, Lee MH, Han HS, Lim JH, Park KU,
Park IH, Cho EK, Yoon SY, Kim JH, Choi IS, Park JH, Choi YJ, Kim HJ, Jung KH, Kim SY, Oh DY, Im SA.
Support Care Cancer. 2015 Oct 1.
[Epub ahead of print]
Link
1700. Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implications.
Ock CY, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Bang YJ, Oh DY.
Gastric Cancer. 2015 May 23.
[Epub ahead of print]
Link
1699. Skeletal Muscle Depletion Predicts the Prognosis of Patients
with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
Choi Y, Oh DY, Kim TY, Lee KH,
Han SW, Im SA, Kim TY, Bang YJ.
PLoS One.
2015 Oct 5;10(10):e0139749.
Link
1698. Concurrent Chemoradiotherapy Versus Chemotherapy Alone for
Unresectable Locally Advanced Pancreatic Cancer:
A Retrospective Cohort Study.
Choi Y, Oh DY, Kim K, Chie EK, Kim TY, Lee KH,
Han SW, Im SA, Kim TY, Ha SW, Bang YJ.
Cancer Res Treat. 2015 Oct 16.
[Epub ahead of print]
Link
1697. Phase II trial of dacomitinib in patients
with HER2-positive gastric cancer.
Oh DY, Lee KW, Cho JY, Kang WK, Im SA,
Kim JW, Bang YJ.
Gastric Cancer. 2015 Nov 18.
[Epub ahead of print]
Link
1696. Pertuzumab in gastrointestinal cancer.
Oh DY, Bang YJ.
Expert Opin Biol Ther. 2015 Nov 30.
[Epub ahead of print]
Link